ABCB1 and cancer: Dendrimers like PAMAM enable targeted drug delivery, co-delivery of siRNA, and overcoming MDR by downregulating P-glycoprotein. Their biocompatibility and ability to restore drug sensitivity are key for treating resistant cancers. Challenges include toxicity and surface charge